D-tetrahydropalmatine
CAS No. 3520-14-7
D-tetrahydropalmatine( —— )
Catalog No. M21452 CAS No. 3520-14-7
D-Tetrahydropalmatine is a organic cation transporter 1 (OCT1) inhibitor it can obviously inhibit the uptake of monocrotaline (MCT) in MDCK-hOCT1 cells and isolate rat primary hepatocytes and attenuate the viability reduction and LDH release of the primary cultured rat hepatocytes caused by MCT.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 56 | In Stock |
|
| 2MG | 35 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 181 | In Stock |
|
| 50MG | 267 | In Stock |
|
| 100MG | 384 | In Stock |
|
| 200MG | 547 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-tetrahydropalmatine
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-Tetrahydropalmatine is a organic cation transporter 1 (OCT1) inhibitor it can obviously inhibit the uptake of monocrotaline (MCT) in MDCK-hOCT1 cells and isolate rat primary hepatocytes and attenuate the viability reduction and LDH release of the primary cultured rat hepatocytes caused by MCT.
-
DescriptionD-Tetrahydropalmatine is a organic cation transporter 1 (OCT1) inhibitor it can obviously inhibit the uptake of monocrotaline (MCT) in MDCK-hOCT1 cells and isolate rat primary hepatocytes and attenuate the viability reduction and LDH release of the primary cultured rat hepatocytes caused by MCT.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3520-14-7
-
Formula Weight355.4
-
Molecular FormulaC21H25NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (140.67 mM)
-
SMILESCOc(ccc(C1)c2CN(CC3)[C@H]1c(cc1OC)c3cc1OC)c2OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Butin
Butin is a major biologically active flavonoid isolated from the heartwood of Dalbergia odorifera with oral activity, with strong antioxidant, antiplatelet and anti-inflammatory activities. Butin significantly alleviates myocardial infarction and improves heart function, together with prevents diabetes-induced cardiac oxidative damage in rat.
-
GSK329
GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
-
pep2-SVKI
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).
Cart
sales@molnova.com